Alzheimer's drug that slows decline given green light in UK - but won't be available on NHS

A key clinical trial has shown lecanemab can slow the decline in memory and mental agility by 27% in patients with mild Alzheimer's. But it can also cause swelling and bleeding in the brain of some patients.

Thursday 22 August 2024 10:34, UK

A drug that can slow the debilitating symptoms of Alzheimer's has been approved by the UK's medicines regulator, but won't be available on the NHS.
Why you can trust Paste BN

Watch Next